白血病的

CML, among the most common forms of leukemia, affects about 4,500 people in the United States each year.

慢性粒细胞白血病是最常见的白血病之一。在美国，每年约有4500人罹患慢性粒细胞白血病。

Advance basic research has confirmed that the alkaloids extracted from thunberg fritillary bulb which is widely used in clinical medicine in vitro and in animal experiments have reversed MDR of leukemia. It will increase resistance of acute leukemia cells anticancer drug concentration and lower resistance the expression of Pgp. Pre-Clinical Experimental Research also shows that the conventional chemotherapy combined with the powder of thunberg fritillary bulb for the treatment of acute leukemia. Clinical complete response rate was higher, especially for patients with refractory or relapsed leukemia patients better clinical remission rate. In addition, Caladium particles Slices with chemotherapy in the treatment of RAL Clinical studies also show the Chinese refractory leukemia improve clinical efficacy safe and reliable.

先期基础研究已证实：临床常用的化痰散结中药浙贝母提取的生物碱体外及动物实验均有逆转白血病多药耐药的生物活性，能增加耐药的急性白血病细胞内抗癌药物浓度，降低耐药蛋白Pgp的表达；临床预实验研究也表明，常规化疗方案配合浙贝母粉用于急性白血病临床治疗，其临床完全缓解率明显高于对照组，尤其对难治及复发白血病患者临床缓解率更佳；此外，单药浙贝母颗粒配合化疗治疗RAL的临床研究亦显示中药在提高难治性白血病临床疗效方面安全可靠。

Context Pediatric acute lymphoblastic leukemia is the prototype for a drug-responsive malignancy. Although cure rates exceed 80%, considerable unexplained interindividual variability exists in treatment response.

根据文章的背景资料，儿科的急性成淋巴细胞性白血病的治愈率已经从1960年代的不到10%增加至如今的80%以上，但是这些病儿对治疗的反应却存在着相当大的且无法解释的个体差异。

WTHZ Results The telomerase activity and expression of telomerase rela ted genes were significantly higher in 42 leukemia patients in progress stage th an that in complete remission/chronic stage and in normal/anemia cases (P.01).The telomerase activity and expression of TP1,hTR gene in 14 cases of acute leuk emia complete remission/chronic myelogenous-chronic stage were h igher than that in normal/anemia cases (P.05). Low levels of telom erase activi ty and telomerase related genes expression could be detected in part of normal b one marrow cells. The levels of telomerase activity and telomerase related genes expression in 3 cases of anemia increased after short-term culture.

结果 42例白血病进展阶段标本的端粒酶活性和相关基因表达水平高于急性白血病完全缓解期、慢性粒细胞白血病慢性期、正常和贫血标本（P.01）；14例急性白血病完全缓解期和慢粒慢性期标本端粒酶活性和TP1、hTR基因表达水平高于正常和贫血标本（P.05）；在部分正常和贫血标本中检测到相对低水平的端粒酶活性和相关基因表达，3例贫血标本经短期常规培养后检测到端粒酶活性和基因表达增高。

Results Among the 104 primary acute leukemia patients, the number of patients with T lymphocyte leukemia,B lymphocyte leukemia,acute myeloblastic leukemia,mixed phenotype acute leukemia and umclassified leukemia were 4(3.8％),38(36.5％),58(55.8％),2(1.9％),and 2(1.9％),respectively.

结果 104例初发急性白血病中，T淋巴细胞白血病4例(3.8％)，B淋巴细胞白血病38例(36.5％)，急性髓细胞白血病58例(55.8％)，急性混合性白血病2例(1.9％)，未行明确分类的2例(1.9％)。

Methods A total of 37 leukemia patients treated with Allo-HSCT were included in the analysis, 11 with acute myeloid leukemia in first remission, 11 with acute lymphocytic leukemia in CR1 and the other 15 with chronic myelocytic leukemia in chronic phase.

1999年4月～2007年12月，应用Allo-HSCT治疗各类白血病患者37例，其中第1次完全缓解期急性髓细胞白血病和急性淋巴细胞白血病各11例，慢性期的慢性粒细胞性白血病15例。

METHODS: Bone marrow mononuclear cells were isolated from 5M4/M5 leukemia patients with high CD14 expression, and then divided into 3groups: adherent leukemia cells, nonadherent blasts, and total unfractioned blasts.

取5例初诊CD14高表达的M4或M5型白血病患者的骨髓标本，分离单个核细胞(bone marrow mononuclearcells，BMMNCs)，将白血病细胞分为3组：贴壁白血病细胞组、非贴壁白血病细胞组及总白血病细胞组。

Methods: Examine 10 person who are healthy and 10 patiens with Weifen syndrome of un-acute leukemia, 5 patients with Weifen syndrome of Acute leukemia and 12 patients with Qifen syndrome of unacute leukemia,6 patients with Qifen syndrome of acute leukemia ,10 patients with Yingfen of unacute leukemia and Yingfen of Acute leukemia,then compare the result's.

通过临床初步研究，检测了10例健康者、10例非急性白血病卫分证患者、5例急性白血病卫分证患者、12例非急性白血病气分证患者、6例急性白血病气分证患者、10例非急性白血病营分证患者、10例急性白血病营分证患者血清上述指标水平，比较了各组以上各指标水平的表达。

Furthermore, preliminary work also performed to examine whether PI3K/AKT signal transduction pathway was activated in the process of refractory leukemia development. Materials and methods An immortalized human bone marrow stromal cell line, HS-5, was introduced to establish a bi-phase culture system for the cultivation of B-lineage precursor leukemia cells. ELISA and RT-PCR were used to investigate the expression of VEGF and its receptors in the leukemia cell lines and primary childhood leukemia cells in different treated groups. Flow cytometory method and immunofluorescent staining were employed to examine the apoptosis signals both in the VP16 treated and untreated leukemia cells. Western blot was utilized to explore the PI3K/AKT activated status in the drug induced or uninduced leukemia cells and lymphocytes from healthy donors.

材料和方法使用来源于人类骨髓基质细胞的细胞株HS-5作为滋养层细胞进行急性淋巴细胞性白血病细胞的体外培养，通过细胞生物学和免疫学方法评估培养体系并鉴定出难治性白血病细胞克隆；以ELISA和RT-PCR方法检测急性白血病细胞株和患儿白血病细胞VEGF及其受体的表达，了解不同治疗阶段VEGF及其受体的表达状况，并结合临床指标进行分析，明确VEGF及其受体在白血病发生过程中的作用；流式细胞仪和免疫荧光染色法对正常健康儿童、初发白血病患儿、复发白血病患儿及缓解后患儿进行凋亡因子检测和分析，初步阐明难治性白血病抗凋亡形成的原因；蛋白印记分析检测PI3K/AKT信号传导通路在健康儿童、初发白血病和复发白血病患儿的表达，初步了解难治性白血病形成的分子生物学机制。

A significant time-and-concentration-dependent inhibition of cell growth was found in all the cells treated with berbamine.

利用建立的人白血病裸鼠异种移植模型，在体外与体内研究小檗胺对多种类型白血病细胞的作用，明确小檗胺是否能诱导多种白血病细胞凋亡以及多种凋亡相关基因在其诱导细胞凋亡中的作用，为小檗胺有可能开发成为新型的抗白血病药物，并应用于临床治疗，提供实验和理论依据。

This one mode pays close attention to network credence foundation of the businessman very much.

这一模式非常关注商人的网络信用基础。

Cell morphology of bacterial ghost of Pasteurella multocida was observed by scanning electron microscopy and inactivation ratio was estimated by CFU analysi.

扫描电镜观察多杀性巴氏杆菌细菌幽灵和菌落形成单位评价遗传灭活率。